Relationship between the GOLD combined COPD assessment staging system and bacterial isolation

International Journal of COPD

Volumn 9, Issue , 2014, Pages 1045-1051

  Aydemir, Yusuf ^a   Aydemir, Özlem ^a   Kalem, Fatma ^b  

^a SAKARYA UNIVERSITY   (Turkey)

^b ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Acute exacerbation; Bacterial etiology; Chronic obstructive pulmonary disease; GOLD; Polymerase chain reaction

Indexed keywords

ACINETOBACTER BAUMANNII; ACUTE DISEASE; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM ISOLATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE EXACERBATION; ESCHERICHIA COLI; FEMALE; FORCED EXPIRATORY VOLUME; GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE STAGE; HAEMOPHILUS INFLUENZAE; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MICROBIAL DIVERSITY; MIXED INFECTION; MORAXELLA CATARRHALIS; NONHUMAN; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; BACTERIA; BACTERIUM IDENTIFICATION; CLASSIFICATION; COMPARATIVE STUDY; DISEASE COURSE; GENETICS; ISOLATION AND PURIFICATION; LUNG; MICROBIOLOGY; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRE; RESPIRATORY TRACT INFECTIONS; SEVERITY OF ILLNESS INDEX; SPUTUM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BACTERIA; BACTERIAL TYPING TECHNIQUES; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; RESPIRATORY TRACT INFECTIONS; SEVERITY OF ILLNESS INDEX; SPUTUM;

EID: 84907811600     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S70620     Document Type: Article

References (28)

1. National Heart, Lung, and Blood Institute. World Health Organization. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Workshop Report 2011. Vestbo J. National Institutes of Health; 2014. Available from: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html. Accessed August 15, 2014.
2. Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(5 Pt 1):1418-1422.
3. Hurst JR, Vestbo J, Anzueto A, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128-1138.
4. Celli BR, Thomas NE, Anderson JA, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med. 2008;178(4):332-338.
5. Zhang M, Li Q, Zhang XY, et al. Relevance of lower airway bacterial colonization, airway inflammation, and pulmonary function in the stable stage of chronic obstructive pulmonary disease. Eur J Clin Microbiol Infect Dis. 2010;29(12):1487-1493.
6. Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med. 2008;359(22): 2355-2365.
7. Yusen RD. Evolution of the GOLD documents for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Controversies and questions. Am J Respir Crit Care Med. 2013;188(1):4-5.
8. Eller J, Ede A, Schaberg T, et al. Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function. Chest. 1998;113(6):1542-1548.
9. Miravitlles M, Espinosa C, Fernández-Laso E, et al. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD. Chest. 1999;116(1):40-46.
10. Soler N, Agustí C, Angrill J, et al. Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease. Thorax. 2007;62(1):29-35.
11. Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106(2):196-204.
12. Stockley RA, O’Brien C, Pye A, et al. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. 2000. Chest. 2009;136(Suppl 5):e30.
13. Miravittles M. Epidemiology of chronic obstructive pulmonary disease exacerbations. Clin Pulm. Med. 2002;9(4):191-197.
14. Wedzicha JA, Donaldson GC. Exacerbations of chronic obstructive pulmonary disease. Respir Care. 2003;48(12):1204-1213.
15. Li XJ, Li Q, Si LY, et al. Bacteriological differences between COPD exacerbation and community-acquired pneumonia. Respir Care. 2011;56(11):1818-1824.
16. Roche N, Kouassi B, Rabbat A, et al. Yield of sputum microbiological examination in patients hospitalized for exacerbations of chronic obstructive pulmonary disease with purulent sputum. Respiration. 2007;74(1):19-25.
17. Huang YJ, Lynch SV, Wiener-Kronish JP. From microbe to microbiota: considering microbial community composition in infections and airway diseases. Am J Respir Crit Care Med. 2012;185(7):691-692.
18. Curran T, Coyle PV, McManus TE, et al. Evaluation of real-time PCR for the detection and quantification of bacteria in chronic obstructive pulmonary disease. FEMS Immunol Med Microbiol. 2007;50(1):112-118.
19. Morozumi M, Nakayama E, Iwata S, et al. Simultaneous detection of pathogens in clinical samples from patients with community-acquired pneumonia by real-time PCR with pathogen-specific molecular beacon probes. J Clin Microbiol. 2006;44(4):1440-1446.
20. Strålin K, Korsgaard J, Olcén P. Evaluation of a multiplex PCR for bacterial pathogens applied to bronchoalveolar lavage. Eur Respir J. 2006;28(3):568-575.
21. Brumfıtt W, Wılloughby ML, Bromley LL. An evaluation of sputum examination in chronic bronchitis. Lancet. 1957;270(7009): 1306-1309.
22. Cabello H, Torres A, Celis R, et al. Bacterial colonization of distal airways in healthy subjects and chronic lung disease: a bronchoscopic study. Eur Respir J. 1997;10(5):1137-1144.
23. Rosell A, Monsó E, Soler N, et al. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med. 2005;165(8):891-897.
24. Garcha DS, Thurston SJ, Patel AR, et al. Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD. Thorax. 2012;67(12):1075-1080.
25. Veeramachaneni SB, Sethi S. Pathogenesis of bacterial exacerbations of COPD. COPD. 2006;3(2):109-115.
26. Patel IS, Seemungal TA, Wilks M, et al. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax. 2002;57(9):759-764.
27. Sethi S, Evans N, Grant BJ, Murphy TF. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 2002;347(7):465-471.
28. Perotin JM, Dury S, Renois F, et al. Detection of multiple viral and bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a pilot prospective study. J Med Virol. 2013;85(5): 866-873.